SCN Signs Major World-Wide Distribution Agreement for Patented Immune Product
Scandinavian Clinical Nutrition AB (SCN) through its subsidiary has entered into a wide-ranging marketing and distribution agreement with US-based Aerus, formerly Electrolux North America. The agreement gives the direct sales company of Aerus Holdings, Naturals for Life, the world-wide exclusive rights to sell SCN’s patented immune product Immulina as a food supplement, with exception for markets where SCN already has partners in place.
For more information, please contact:
Danilo Copiz, VP Sales,
, +45 2090 8885
Ulf Söderberg, CEO,
, +46 708 13 22 81Scandinavian Clinical Nutrition i Sverige AB (publ) works in R&D and distribution of clinically tested, scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as thin400, CUUR, Coldizin, Immulina, Membra7 and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and clinically proven products, create good conditions for profitable growth both in Sweden and internationally. The shares of SCN are traded under the ticker “SCN” on Oslo Axess (
www.osloaxess.no) and NGM Equity (
www.ngm.se). For more information, please visit
www.scnutrition.com.